You are here » Home » Companies » Company Overview » Parnax Lab Ltd

Parnax Lab Ltd.

BSE: 506128 Sector: Health care
NSE: N.A. ISIN Code: INE383L01019
BSE 00:00 | 07 Aug 16.25 -1.10
(-6.34%)
OPEN

16.50

HIGH

18.75

LOW

16.20

NSE 05:30 | 01 Jan Parnax Lab Ltd
OPEN 16.50
PREVIOUS CLOSE 17.35
VOLUME 3522
52-Week high 31.00
52-Week low 11.65
P/E
Mkt Cap.(Rs cr) 14
Buy Price 16.15
Buy Qty 120.00
Sell Price 17.90
Sell Qty 139.00
OPEN 16.50
CLOSE 17.35
VOLUME 3522
52-Week high 31.00
52-Week low 11.65
P/E
Mkt Cap.(Rs cr) 14
Buy Price 16.15
Buy Qty 120.00
Sell Price 17.90
Sell Qty 139.00

Parnax Lab Ltd. (PARNAXLAB) - Director Report

Company director report

To

The members of Parnax Lab Limited.

Your Directors have pleasure in presenting the 37th Annual Report together with theAudited Financial Statements for the year ended on 31st March 2019.

1. FINANCIAL RESULTS:

(Standalone basis)
Amount in Rs.
Particulars For the year ended on 31 March 2019 For the year ended on 31 March 2018
Revenue from Operations 64926243 58030879
Profit/ (Loss) before Depreciation and Tax (4600248) (20349679)
Less: Depreciation 483938 4411273
Tax Expenses 3190367 (763951)
Net Profit/ (Loss) for the year (8274553) (23997001)
Add. Profit & Loss A/c Bal of Previous year (63334577) (39337577)
Appropriations:
Proposed Dividend NIL NIL
Dividend Distribution Tax on Proposed Dividend N.A. N.A.
Transfer to General Reserve NIL NIL
Balance c/f to Balance Sheet as at 31.03.2019. (71609130) (63334577)

2. STATEMENT OF COMPANY'S AFFAIRS:

During the year the net income from operations on standalone basis Increased from580.34 lakh to 649.26 lakh. The Company is hopeful to improve the result in coming years.

3. DIVIDEND:

The Board recommended no dividend shall be declared for the Financial Year ended on31st March 2019.

4. TRANSFER TO RESERVES:

The Company has not transferred amount to any reserve.

5. CONSERVATION OF ENERGY TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS /OUTGO:

The particulars of Conservation of Energy Technology Absorption and Foreign ExchangeEarnings/outgo are set out in Annexure I to this Report.

6. EXTRACT OF ANNUAL RETURN:

The Extract of Annual Return in Form MGT 9 pursuant to Section 92 (3) of the CompaniesAct 2013 and rule 12 (1) of Companies (Management and Administration) Rules 2014 are asper Annexure II to this Report.

7. MANAGEMENT DISCUSSION AND ANALYSIS:

Management Discussion and Analysis is presented as a separate section as AnnexureIII forming part of this Annual Report.

8. SUBSIDIARY COMPANY:

The Company has one Subsidiary Company as on March 31 2019 namely Naxpar PharmaPrivate Limited. There has been no material change in the nature of business of thesubsidiary company.

Pursuant to the provision of Section 129(3) of the act a statement containing silentfeatures of the financial statements of the company's subsidiary in Form AOC-1 is attachedto the set Report in Annexure IV to this Report.

9. PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES:

During the year 2018-19 the Contract or Arrangements entered in to by the Company withrelated parties were approved by the Audit Committee pursuant to subsection (IV) (4) ofSection 177 of Companies Act 2013 and by the Board of Directors pursuant to Section 188(1) of Companies Act 2013.

The related party transactions were at arm's length basis and were in the ordinarycourse of business of the Company. The other details with respect to related partytransactions in Form AOC 2 are set out in Annexure V to this Report. The policy onRelated Party Transactions is available on Company's website- www.naxparlab.com.

10. PARTICULARS OF REMUNERATION:

In terms of provision of section 197 (12) of the Companies Act 2013 and Rule 5(2) ofCompanies (Appointment and Remuneration of Managerial Personnel) Rules 2014 a statementshowing have been provided in Annexure VI however as there are no employees drawingremuneration in excess of the prescribed limits. The information as required the names andother particulars of employees drawing remuneration in excess of the limits set out in thesaid Rules forms part of the Report However having regard to the provisions of the firstproviso to Section 136(1) of the Companies Act 2013 the Annual Report including theaforesaid information is being sent to the Members of the Company.

11. DEPOSITS:

During the Financial Year 2018-19 The Company has not accepted any public depositcovered under Section 76 of the Companies Act 2013.

12. CORPORATE SOCIAL RESPONSIBILITY:

The Company is not required to constitute a Corporate Social Responsibility Committeeas it does not fall within purview of Section 135 of the Companies Act 2013 and hence itis not required to formulate policy on corporate social responsibility.

13. DISCLOSURE REQUIREMENTS

Policy on dealing with related party transactions is available on the website of theCompany at the link:www.naxparlab.com

The Company has formulated and disseminated a Whistle Blower Policy to provide vigilmechanism for employees and Directors of the Company to report genuine concerns that couldhave serious impact on the operations and performance of the business of the Company. ThisPolicy is in compliance with the provisions of Section 177(9) of the Companies Act 2013and Regulation 4(d)(iv) of the SEBI (Listing Obligations and Disclosure Requirements)Regulations 2015. Policy on Whistle Blower is available on the website of the Company atthe link :www.naxparlab.com

14. BOARD OF DIRECTORS:

During the year 2018-19 there were no changes in the Composition of Board ofDirectors.

At the ensuing 37th (Thirty Seventh) Annual General Meeting of the Company the DirectorMrs. Ami Mihir Shah (DIN 03101049) is liable to retire by rotation and beingeligible offers herself for re-appointment. Board recommends her reappointment to themembers for consideration in the ensuing 37th Annual General Meeting.

15. NUMBER OF MEETINGS OF THE BOARD:

Six (6) Board Meetings were held during the year 2018-19 pursuant to Section 173 (1) ofCompanies Act 2013 on 30th May 2018 14th June 2018 14th August 2018 14th November2018 13th February 2019 and 27th March 2019.

16. DIRECTORS RESPONSIBILITY STATEMENT:

Pursuant to Section 134 (3) (C) of the Companies Act 2013 your Directors state that:

(a) in the preparation of Annual Accounts for the year ended on 31stMarch 2019 theapplicable accounting standards have been followed and there are not material departuresfrom the same.

(b) the Directors have selected such accounting policies and applied them consistentlyand made judgements and estimates that are reasonable and prudent so as to give a true andfair view of the state of affairs of the Company at the end of the financial year on 31stMarch 2019 and the profit and loss of the Company for that period.

(c) the Directors have taken proper and sufficient care for the maintenance of theadequate accounting records in accordance with the provisions of the Companies Act 2013for safeguarding the assets of the Company and for preventing and detecting fraud andother irregularities.

(d) the Directors have prepared Accounts on ‘going concern' basis. and

(e) The Directors have laid down internal financial controls to be followed by theCompany and that such financial controls are adequate and are operating effectively.

(f) The Directors have devised proper systems to ensure compliance with the provisionsof all applicable laws and that such systems are adequate and operating effectively.

17. DECLARATIONS GIVEN BY INDEPENDENT DIRECTORS:

The Company has received necessary declarations from all the Independent Directorsunder Section 149(7) of the Act that they meet the criteria of independence laid down inSection 149(6) of the Act and Regulation 16 of SEBI (Listing Obligations and DisclosureRequirements) Regulations 2015.

18. NOMINATION AND REMUNERATION COMMITTEE:

The Board had constituted Nomination and Remuneration Committee pursuant to theprovisions of subsection (1) of Section 178 of Companies Act 2013. Pursuant to subsection(3) of Section 178 of Companies Act 2013 the Nomination and Remuneration Committee hasformulated the criteria for determining qualifications positive attributes andindependence of a Director and recommended to the Board the policy relating to theremuneration of directors key managerial personnel and other employees. The policy isavailable at Company's website on www.naxparlab.com.

19. PARTICULARS OF LOANS GUARANTEES OR INVESTMENTS:

The particulars of Loans Guarantees and investment made under Section 186 of theCompanies Act 2013 have been disclosed in the financial statements in Notes of theFinancial Statement.

20. MATERIAL CHANGES AND COMMITMENTS AFFECTING THE FINANCIAL POSITION OF THE COMPANY:

There were no material changes and commitments affecting the financial position of theCompany between the end of the financial year of the Company to which the financialstatements relate and the date of the report.

21. PERFORMANCE EVALUATION OF BOARD:

Pursuant to the applicable provisions of the Act and the Listing Regulations the Boardhas carried out an Annual Evaluation of its own performance and working of its Committees.The Board's functioning was evaluated on various aspects including inter alia degree offulfillment of key responsibilities its structure and composition establishment anddelegation of responsibilities to various Committees. Directors were evaluated on aspectssuch as attendance and contribution at Board/ Committee Meetings and guidance/ support tothe management of the Company. Areas on which the Committees of the Board were assessedincluded degree of fulfillment of key responsibilities adequacy of Committee compositionand effectiveness of meetings. The performance evaluation of the Independent Directors wascarried out by the entire Board excluding the Director being evaluated.

The performance evaluation of the Chairman and the Non-Independent Directors wascarried out by the Independent Directors who also reviewed the performance of the Boardas a whole.

22. STATUTORY AUDITORS:

In the Annual General Meeting held on September 29 2017 M/s Ladha Singhal &Associates. Chartered Accountants were appointed as Statutory Auditors of the Companyto hold office till conclusion of 39th Annual General Meeting.

23. COMMENTS ON AUDIT REPORTS:

There are no qualifications reservation or adverse remark or disclaimer made by M/sLadha Singhal & Associates Chartered Accountants audit report for the year endedon 31st March 2019.

The Statutory Auditors have not reported any incident of fraud to the Audit Committeeof the Company in the year under review.

24. INTERNAL AUDITORS:

As per section 138 of the Companies Act 2013. The Company has appointed M/s P S D& Associates Chartered Accountants as the internal auditors for the financialyear to 2019-2020 to conduct the internal audit and to ensure adequacy of the Internalcontrols adherence to Company's policies and ensure statutory and other compliancethrough periodical checks and internal audit.

25. SECRETARIAL AUDITORS REPORT:

The Secretarial Audit Report of M/s HS Associates Company Secretaries for theyear ended on 31st March 2019 is attached to this report as Annexure VII. TheBoard has re-appointed HS Associates Company Secretaries as the SecretarialAuditors of the Company for the Secretarial Audit of the financial year ended on 31stMarch 2020.

26. COMMITTEES OF THE BOARD:

The Board has constituted necessary Committees pursuant to the provisions of CompaniesAct 2013 rules framed thereunder and SEBI (Listing Obligations and DisclosureRequirements) Regulations2015 with Stock Exchanges. The Committees of the Board held bycompany are Audit Committee Stakeholders' Relationship Committee Nomination andRemuneration Committee. The details about Committee Meetings are given below:

Sr. No. Particulars No. of Meetings held
1. Audit Committee 4
2. Stakeholder's Relationship Committee 1
3. Nomination & Remuneration Committee 2

I. Audit Committee:

1. Mr. Vinayak Desai - Chairman

2. Mr. Manhar Jhavari - Member

3. Mr. Baiju Shah Member

II. Stakeholder's Relationship Committee

1. Mr. Vinayak Desai - Chairman

2. Mr. Manhar Jhavari - Member

3. Mr. Baiju Shah Member

III. Nomination & Remuneration Committee

1. Mr. Vinayak Desai - Chairman

2. Mr. Manhar Jhavari - Member

3. Mr. Ami Shah Member

28. WHISTLE BLOWER:

The Board of Directors have set up the Whistle Blower Policy i.e. Vigil Mechanism forDirectors and Employees of the Company to report concerns about unethical behaviouractual or suspected fraud or violations of Company's Code of Conduct or Ethics Policy.The detailed Vigil Mechanism Policy is available at Company's Website www.naxparlab.com.

29. CORPORATE GOVERNANCE:

The Company falls under the criteria 15(2) (a) of the Listing Obligations &Disclosure requirements (LODR) Regulations2015 and the Paid-up capital of the Company wasbelow Rs. 10/- Crores and net worth was below Rs. 25/- Crores as on the last day of theprevious financial year. Hence Corporate Governance Report is not applicable to theCompany.

30. POLICIES:

The Company seeks to Promote Highest levels of ethical standards in the normal businesstransaction guided by the value system. The SEBI (Listing Obligations and DisclosureRequirements) Regulations 2015 mandates formulation of certain policies for ListedCompanies. The Policies are reviewed periodically by the Board and are updated based onthe need and compliance as per the applicable laws and rules and amended from time totime. The policies are available on the website of the Company at www.naxparlab.com.

31. INTERNAL FINANCIAL CONTROLS:

The Board hereby reports that the Internal Financial Controls were reviewed by theAudit Committee and there were adequate Internal Financial Controls existed in the Companywith respect to the Financial Statements for year ended on 31st March 2019 and theInternal Financial Controls are operating effectively.

32. ASSET CLASSIFIED AS HELD FOR SALE:

The company intends to dispose off plant and equipment pertaining to the SilvassaFactory as it no longer intends to be utilized. It was previously utilized in itsmanufacturing facility. The Company is in search of a buyer for sale of plant andequipment.

33. COMPLIANCE WITH SECRETARIAL STANDARDS

The Company has been in compliance with the applicable Secretarial Standards during theFinancial year 2018-2019.

34. CERTIFICATE OF NON-DISQUALIFICATION OF DIRECTORS:

None of the Board of Directors of Parnax Lab Ltd as on 31st March 2019 have beendebarred or disqualified from being appointed or continuing as Directors of the Company bythe Securities and Exchange Board of India Ministry of Corporate Affairs or any suchother Statutory Authority.

A certificate in this regard has been given by M/s HS Associates Company Secretaries.

35. DISCLOSURE UNDER SEXUAL HARASSMENT ACT:

As required by the Sexual Harassment of Women at Workplace (Prevention Prohibition& Redressal) Act 2013 the Company has formulated and implemented a policy onprevention of sexual harassment at workplace with a mechanism of lodging complaintsRedressal for the benefits of its employees. There were no complaints filed against any ofthe employees of the Company under this Act.

36. ACKNOWLEDGMENT:

Your Company wishes to sincerely thank all the customers commercial banks financialinstitution creditors etc. for their continuing support and co-operation.

Your Directors express their appreciation for the dedicated and sincere servicesrendered by the employees of the company and also sincerely thank the shareholders for theconfidence reposed by them in the company and from the continued support and co-operationextended by them.

For and on behalf of the Board
of Parnax Lab Limited
Sd/-
Date : 14 th August 2019 Prakash M. Shah
Place : Mumbai Chairman & CEO
(DIN 00440980)